Mar 26, 2026 · 37m · allin
Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
At The Hill & Valley Forum 2024, Bryan Johnson discusses his recent 5-MeO-DMT experience alongside frontier longevity interventions, framing psychedelics and cellular engineering as core tools for psychological and biological rejuvenation.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
The hosts as informed peer 4.9 Guest teaching 3.0 Guest disagreement 0.3 The hosts pushing back 2.2
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 19:34 Bryan defends high-risk psychedelic protocol against investor concerns
Bryan pushes back against the premise that psychedelic experiences cause reckless abandonment of responsibilities, arguing that 5-MeO-DMT actually emboldened his commitment to his work rather than driving him into the woods.
Hardest push from the hosts ▶ 26:05 Host asserts Bryan's inner circle is enabling reckless riskHost directly rejects Bryan's framing of surrounding himself with supportive friends and family, arguing instead that allowing him to undertake potentially dangerous interventions is enabling rather than supportive.
Biggest teaching moment ▶ 9:35 Bryan reveals novel metabolic biomarker resets from psychedelic trialBryan educates Host on first-in-human observations from his quantified trial, showing how psilocybin shifted his blood glucose baseline from the 99.5th to the 99.9th percentile across the body.
The host holds their own ▶ 27:50 Host details maternal mitochondrial inheritance and sourcing strategyHost demonstrates superior domain expertise by explaining how mitochondrial DNA is inherited maternally through egg cells and advising Bryan to source young mitochondria from his sister's child.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Bryan Johnson Introduces His 5-MeO-DMT Experiment | 3 | 3 | 0 | 1 | Host introduces the episode and asks about high clinical psychedelic doses. Bryan explains his longevity-focused framework and scientific rationale for psilocybin and 5-MeO-DMT. | |
| Navigating the Intense 5-MeO-DMT Journey | 3 | 3 | 0 | 1 | Bryan describes the overwhelming experience of 5-MeO-DMT and ego surrender. Host guides the conversation by asking targeted questions about visual changes and internal monologue. | |
| Default Mode Network Dissolution and Neuroplasticity | 7 | 4 | 0 | 2 | When Bryan introduces the Default Mode Network and Kernel brain data, Host steps in to explain the underlying mechanism of neuroplasticity and neural rewiring. Host demonstrates strong neuroscientific literacy. | |
| Systemic Biomarker Resets and Childlike Restorations | 2 | 4 | 0 | 0 | Bryan details N=1 biomarker findings from psychedelic protocols, including blood glucose resets and childlike mood restorations. Host listens and asks clarifying questions. | |
| Real-World Relational Shifts and Historical Context | 2 | 3 | 0 | 1 | Bryan discusses real-world relational dynamics and his history of therapeutic psychedelic use post-divorce and leaving Mormonism. Host adds light banter about storing up interpersonal grievances. | |
| Quantifying Brain Rejuvenation and Safety Considerations | 5 | 3 | 0 | 1 | Host clearly delineates structural versus functional brain MRI modalities to explain how neurological changes are tracked. Bryan agrees and lists his quantification methods. | |
| Psychosis Risks, Identity Shifts, and Human Adaptation to AI | 6 | 3 | 1 | 6 | Host pushes back strongly on the uncritical adoption of psychedelics, citing risks of permanent psychosis, family destruction, and VC deal clauses banning psychedelic use. Host also explores philosophical questions regarding identity. | |
| Frontier Interventions, Personal Trauma, and Fatherhood | 5 | 2 | 2 | 7 | Host challenges Bryan's psychological motivations, asking if his extreme risk-taking stems from childhood trauma and suggesting his inner circle is enabling rather than supporting him. Bryan defends his commitment to fatherhood while acknowledging his trauma response. | |
| Mitochondrial Augmentation and Functional Athletic Metrics | 8 | 3 | 0 | 2 | Host demonstrates deep technical knowledge of mitochondrial genetics, explaining maternal inheritance lines and suggesting harvesting mitochondria from a nephew/niece as well as functional sprinting metrics. Bryan enthusiastically adopts Host's suggestions. | |
| Plasmids, Gene Therapy, and FOXL-III Expression | 7 | 3 | 0 | 1 | Host explains the biological process of turning blood cells into induced pluripotent stem cells using Yamanaka factors to create organoids for the audience. Bryan shares his dish-testing strategy. | |
| Yamanaka Factors, New Limit, and Cellular Control | 8 | 2 | 0 | 2 | Host identifies the primary safety risk of Yamanaka factors—tumorigenesis from improper dosing—and proposes synthetic cellular switches as the solution. Bryan agrees that control mechanisms are essential. | |
| Psychedelics and Psychological Rejuvenation | 3 | 3 | 0 | 2 | Host questions why Bryan continues experimenting with psychedelics when advanced cellular and gene therapies exist. Bryan explains that psychedelics provide unique psychological rejuvenation that physical therapies cannot match. |
Statements from this episode (15)
Bryan Johnson: Blueprint conducted the world's most quantified psilocybin experiment
“And so we did the world's most studied, the most quantified experiment doing psilocybin, three doses at 25 milligrams of psilocybin.”
Bryan Johnson: Kernel scans show psilocybin generated new neural connectivity
“So you look at my brain on psilocybin from Kernel, you see my patterns before, like the New York to London connection. You see my brain afterwards, and it's exactly what you said. New patterns are emergent. The old ones have quieted down. It's like a new map o…”
Bryan Johnson says psilocybin triggered a metabolic reset and microbiome shift
“What we found in psilocybin though, is it had, we found a first in human observation. It had this metabolic reset in the brain where my blood glucose before this was in the top. 99.5 percentile of all the population. Okay. After it went to the top 99.9 percent…”
Bryan Johnson: 5-MeO-DMT annihilates the default mode network compared to psilocybin
“Five MEO DMT compared to psilocybin, like just absolutely like blasted clean. My default mode network. It felt like psilocybin dampens it, like it softens it, but this thing just annihilated my default mode network.”
Bryan Johnson: Blueprint rejuvenated heart and lungs, but brain is harder
“We've had a lot of success rejuvenating my heart and my lungs and muscle and body fat, but rejuvenating the brain is very hard.”
Bryan Johnson: 5-MeO-DMT was more efficacious than diet and exercise combined
“If I just subjectively compare my experience with five MEO to having a better diet and exercising every day and sleeping well and doing the sauna and doing hyperbolic oxygen therapy, this was more efficacious than all of them. In terms of the reset of me as a …”
Bryan Johnson: VCs put anti-psychedelic clauses in founder deal documents
“One investor told me that he even put it in the deal docs that, you know, if we invest, you're not going to do these psychedelics because they wanted to minimize the risk profile.”
Bryan Johnson: Blueprint targets mitochondrial rejuvenation after exhausting existing treatments
“We've knocked out all the stuff you can do today. Like we've gone through it all, done it all. The next gen therapies are just not there yet. So we're looking at mitochondrial rejuvenation.”
Bryan Johnson: Sprinting is an underappreciated longevity therapy
“Sprinting is one of the most underappreciated longevity therapies.”
Bryan Johnson: FOXL-III stem cell therapy showed over 50% tissue rejuvenation
“So the mesenchymal stem cells, you know, packaged up with the FOXL-III delivery you know, that showed that over 50% of tissue is getting that rejuvenation.”
Bryan Johnson: Developing in-house FOXL-III gene therapy is a two-year project
“That's like a two-year project.”
Bryan Johnson created personal organoids to test longevity drugs in vitro
“We have the organoids stood up. We haven't done our first takes yet.”
Bryan Johnson: New Limit computationally solved cellular reprogramming factor discovery
“They've done, I mean, they've made remarkable progress. They figured out how to computationally Solve the discovery process. And so they they're much faster than they initially thought.”
Bryan Johnson: GLP-1s and plasmid therapies will drive major longevity shifts
“In the future, like, I think we'll look back and we'll see GLP ones as the first big drop. Like what I can just inject myself and like it solves hunger and totally. Yeah. And then the second will probably be something like new limit or one of these Fox, one of…”
Bryan Johnson: Psychedelics provided 30 to 40 years of psychological rejuvenation
“I felt like it was like 30, 40 years of Psychological rejuvenation. Like, you know, it's like to transform me back to a childlike state. That is insane. I don't get that from the sauna. Or from eating well. Or from sleeping well.”